Does VINDESINE Cause Agranulocytosis? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Agranulocytosis have been filed in association with VINDESINE. This represents 2.6% of all adverse event reports for VINDESINE.
51
Reports of Agranulocytosis with VINDESINE
2.6%
of all VINDESINE reports
6
Deaths
25
Hospitalizations
How Dangerous Is Agranulocytosis From VINDESINE?
Of the 51 reports, 6 (11.8%) resulted in death, 25 (49.0%) required hospitalization, and 7 (13.7%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINDESINE. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does VINDESINE Cause?
Myelosuppression (429)
Off label use (148)
Bone marrow failure (141)
Pyrexia (138)
Anaemia (137)
Leukopenia (127)
White blood cell count decreased (124)
Febrile neutropenia (115)
Pneumonia (110)
Thrombocytopenia (93)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which VINDESINE Alternatives Have Lower Agranulocytosis Risk?
VINDESINE vs VINORELBINE
VINDESINE vs VINORELBINE\VINORELBINE
VINDESINE vs VIREAD
VINDESINE vs VISIPAQUE
VINDESINE vs VISMODEGIB